Abstract
Glycine has multiple neurotransmitter functions in the central nervous system (CNS). In the spinal cord and brainstem of vertebrates, it serves as a major inhibitory neurotransmitter. In addition, it participates in excitatory neurotransmission by modulating the activity of the N-methyl-d-aspartate (NMDA) subtype of glutamate receptors. The extracellular concentrations of glycine are regulated by Na+/Cl−-dependent glycine transporters (GlyTs), which are expressed in neurons and adjacent glial cells. Considerable progress has been made recently towards elucidating the in vivo roles of GlyTs in the CNS. The generation and analysis of animals carrying targeted disruptions of GlyT genes (GlyT knockoutmice) have allowed investigators to examine the different contributions of individual GlyT subtypes to synaptic transmission. In addition, they have provided animal models for two hereditary human diseases, glycine encephalopathy and hyperekplexia. Selective GlyT inhibitors have been shown to modulate neurotransmission and might constitute promising therapeutic tools for the treatment of psychiatric and neurological disorders such as schizophrenia and pain. Therefore, pharmacological and genetic studies indicate that GlyTs are key regulators of both glycinergic inhibitory and glutamatergic excitatory neurotransmission. This chapter describes our present understanding of the functions of GlyTs and their involvement in the fine-tuning of neuronal communication.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams RH, Sato K, Shimada S, Tohyama M, Puschel AW, Betz H (1995) Gene structure and glial expression of the glycine transporter GlyT1 in embryonic and adult rodents. J Neurosci 15:2524–2532
Ahmadi S, Muth-Selbach U, Lauterbach A, Lipfert P, Neuhuber WL, Zeilhofer HU (2003) Facilitation of spinal NMDA receptor currents by spillover of synaptically released glycine. Science 300:2094–2097
Applegarth DA, Toone JR (2001) Nonketotic hyperglycinemia (glycine encephalopathy): laboratory diagnosis. Mol Genet Metab 74:139–146
Ashton H, Young AH (2003) GABA-ergic drugs: exit stage left, enter stage right. J Psychopharmacol 17:174–178
Aubrey KR, Vandenberg RJ (2001) N[3-(4′-fluorophenyl)-3-(4′-phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport. Br J Pharmacol 134:1429–1436
Barmack NH, Guo H, Kim HJ, Qian H, Qian Z (1999) Neuronally modulated transcription of a glycine transporter in rat dorsal cochlear nucleus and nucleus of the medial trapezoid body. J Comp Neurol 415:175–188
Becker L, Hartenstein B, Schenkel J, Kuhse J, Betz H, Weiher H (2000) Transient neuromotor phenotype in transgenic spastic mice expressing low levels of glycine receptor betasubunit: an animal model of startle disease. Eur J Neurosci 12:27–32
Berger AJ, Dieudonne S, Ascher P (1998) Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses. J Neurophysiol 80:3336–3340
Betz H, Harvey RJ, Schloss P (2000) Structures, diversity and pharmacology of glycine receptors and transporters. In: Möhler H (ed) Pharmacology of GABA and glycine neurotransmission. Springer-Verlag, Heidelberg Berlin New York, pp 375–401
Blakely RD, De Felice LJ, Hartzell HC (1994) Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 196:263–281
Boneh A, Degani Y, Harari M (1996) Prognostic clues and outcome of early treatment of nonketotic hyperglycinemia. Pediatr Neurol 15:137–141
Borowsky B, Hoffman BJ (1998) Analysis of a gene encoding two glycine transporter variants reveals alternative promoter usage and a novel gene structure. J Biol Chem 273:29077–29085
Borowsky B, Mezey E, Hoffman BJ (1993) Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene. Neuron 10:851–863
Bradaia A, Schlichter R, Trouslard J (2004) Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord. J Physiol 559:169–186
Brenman JE, Bredt DS (1997) Synaptic signaling by nitric oxide. Curr Opin Neurobiol 7:374–378
Caulfield WL, Collie IT, Dickins RS, Epemolu O, McGuire R, Hill DR, McVey G, Morphy JR, Rankovic Z, Sundaram H (2001) The first potent and selective inhibitors of the glycine transporter type 2. J Med Chem 44:2679–2682
Chatonnet F, del Toro ED, Voiculescu O, Charnay P, Champagnat J (2002) Different respiratory control systems are affected in homozygous and heterozygous kreisler mutantmice. Eur J Neurosci 15:684–692
Cubelos B, Gimenez C, Zafra F (2005) Localization of the GLYT1 Glycine Transporter at Glutamatergic Synapses in the Rat Brain. Cereb Cortex 15:448–459
Danglot L, Rostaing P, Triller A, Bessis A (2004) Morphologically identified glycinergic synapses in the hippocampus. Mol Cell Neurosci 27:394–403
Ebihara S, Yamamoto T, Obata K, Yanagawa Y (2004) Gene structure and alternative splicing of the mouse glycine transporter type-2. Biochem Biophys Res Commun 317:857–864
Ellory JC, Jones SE, Young JD (1981) Glycine transport in human erythrocytes. J Physiol 320:403–422
Eulenburg V, Armsen W, Betz H, Gomeza J (2005) Glycine transporters: essential regulators of neurotransmission. Trends Biochem Sci 30:325–333
Fornes A, Nunez E, Aragon C, Lopez-Corcuera B (2004) The second intracellular loop of the glycine transporter 2 contains crucial residues for glycine transport and phorbol ester-induced regulation. J Biol Chem 279:22934–22943
Friauf E, Aragon C, Lohrke S, Westenfelder B, Zafra F (1999) Developmental expression of the glycine transporter GLYT2 in the auditory system of rats suggests involvement in synapse maturation. J Comp Neurol 412:17–37
Gabernet L, Pauly-Evers M, Schwerdel C, Lentz M, Bluethmann H, Vogt K, Alberati D, Mohler H, Boison D (2005) Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression. Neurosci Lett 373:79–84
Gammelsaeter R, Froyland M, Aragon C, Danbolt NC, Fortin D, Storm-Mathisen J, Davanger S, Gundersen V (2004) Glycine, GABA and their transporters in pancreatic islets of Langerhans: evidence for a paracrine transmitter interplay. J Cell Sci 117:3749–3758
Geerlings A, Lopez-Corcuera B, Aragon C (2000) Characterization of the interactions between the glycine transporters GLYT1 and GLYT2 and the SNARE protein syntaxin 1A. FEBS Lett 470:51–54
Geerlings A, Nunez E, Lopez-Corcuera B, Aragon C (2001) Calcium-and syntaxin 1-mediated trafficking of the neuronal glycine transporter GLYT2. J Biol Chem 276:17584–17590
Gomeza J, Hulsmann S, Ohno K, Eulenburg V, Szoke K, Richter D, Betz H (2003a) Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron 40:785–796
Gomeza J, Ohno K, Hulsmann S, Armsen W, Eulenburg V, Richter DW, Laube B, Betz H (2003b) Deletion of themouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 40:797–806
Guastella J, Brecha N, Weigmann C, Lester HA, Davidson N (1992) Cloning, expression, and localization of a rat brain high-affinity glycine transporter. Proc Natl Acad Sci U S A 89:7189–7193
Hanley JG, Jones EM, Moss SJ (2000) GABA receptor rho1 subunit interacts with a novel splice variant of the glycine transporter, GLYT-1. J Biol Chem 275:840–846
Harsing LG Jr, Gacsalyi I, Szabo G, Schmidt E, Sziray N, Sebban C, Tesolin-Decros B, Matyus P, Egyed A, Spedding M, Levay G (2003) The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study. Pharmacol Biochem Behav 74:811–825
Hartenstein B, Schenkel J, Kuhse J, Besenbeck B, Kling C, Becker CM, Betz H, Weiher H (1996) Low level expression of glycine receptor beta subunit transgene is sufficient for phenotype correction in spastic mice. EMBO J 15:1275–1282
Ho KK, Appell KC, Baldwin JJ, Bohnstedt AC, Dong G, Guo T, Horlick R, Islam KR, Kultgen SG, Masterson CM, McDonald E, McMillan K, Morphy JR, Rankovic Z, Sundaram H, Webb M (2004) 2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitors. Bioorg Med Chem Lett 14:545–548
Hollmann M (1999) Structure of ionotropic glutamate receptors. In: Jonas P, Monyer H (eds) Ionotropic glutamate receptors in the CNS (Handbook of experimental pharmacology). Springer-Verlag, Heidelberg Berlin New York, pp 1–98
Horiuchi M, Loebrich S, Brandstaetter JH, Kneussel M, Betz H (2005) Cellular localization and subcellular distribution of Unc-33-like protein 6, a brain-specific protein of the collapsin response mediator protein family that interacts with the neuronal glycine transporter 2. J Neurochem 94:307–315
Hubner CA, Stein V, Hermans-Borgmeyer I, Meyer T, Ballanyi K, Jentsch TJ (2001) Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition. Neuron 30:515–524
Hulsmann S, Oku Y, Zhang W, Richter DW (2000) Metabolic coupling between glia and neurons is necessary for maintaining respiratory activity in transverse medullary slices of neonatal mouse. Eur J Neurosci 12:856–862
Isaac M, Slassi A, Silva KD, Arora J, MacLean N, Hung B, McCallum K (2001) 5,5-Diaryl-2-amino-4-pentenoates as novel, potent, and selective glycine transporter type-2 reuptake inhibitors. Bioorg Med Chem Lett 11:1371–1373
Javitt DC (2002) Glycine modulators in schizophrenia. Curr Opin Investig Drugs 3:1067–1072
Javitt DC, Balla A, Burch S, Suckow R, Xie S, Sershen H (2003) Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists. Neuropsychopharmacology 29:300–307
Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201–225
Johnson JW, Ascher P (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325:529–531
Jones EM, Fernald A, Bell GI, Le Beau MM (1995) Assignment of SLC6A9 to human chromosome band 1p33 by in situ hybridization. Cytogenet Cell Genet 71:211
Jursky F, Nelson N (1995) Localization of glycine neurotransmitter transporter (GLYT2) reveals correlation with the distribution of glycine receptor. J Neurochem 64:1026–1033
Jursky F, Nelson N (1996) Developmental expression of the glycine transporters GLYT1 and GLYT2 in mouse brain. J Neurochem 67:336–344
Kim KM, Kingsmore SF, Han H, Yang-Feng TL, Godinot N, Seldin MF, Caron MG, Giros B (1994) Cloning of the human glycine transporter type 1:molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes. Mol Pharmacol 45:608–617
Kinney GG, Sur C, Burno M, Mallorga PJ, Williams JB, Figueroa DJ, Wittmann M, Lemaire W, Conn PJ (2003) The glycine transporter type 1 inhibitor N-[3-(4′-fluorophenyl)-3-(4′-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior. J Neurosci 23:7586–7591
Laube B, Kuhse J, Betz H (1998) Evidence for a tetrameric structure of recombinant NMDA receptors. J Neurosci 18:2954–2961
Laube B, Maksay G, Schemm R, Betz H (2002) Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses? Trends Pharmacol Sci 23:519–527
Legendre P (2001) The glycinergic inhibitory synapse. Cell Mol Life Sci 58:760–793
Lim R, Hoang PD, Berger AJ (2004) Blockade of glycine transporter-1 (GLYT-1) potentiates NMDA-receptor mediated synaptic transmission in hypoglossal motoneurons. J Neurophysiol 92:2530–2537
Lipina T, Labrie V, Weiner I, Roder J (2005) Modulators of the glycine site on NMDA receptors, D:-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia. Psychopharmacology (Berl) 179:54–67
Liu QR, Nelson H, Mandiyan S, Lopez-Corcuera B, Nelson N (1992) Cloning and expression of a glycine transporter from mouse brain. FEBS Lett 305:110–114
Liu QR, Lopez-Corcuera B, Mandiyan S, Nelson H, Nelson N (1993) Cloning and expression of a spinal cord-and brain-specific glycine transporter with novel structural features. J Biol Chem 268:22802–22808
Lopez-Corcuera B, Aragon C (1989) Solubilization and reconstitution of the sodium-and-chloride-coupled glycine transporter from rat spinal cord. Eur J Biochem 181:519–524
Lopez-Corcuera B, Vazquez J, Aragon C (1991) Purification of the sodium-and chloridecoupled glycine transporter from central nervous system. J Biol Chem 266:24809–24814
Lopez-Corcuera B, Martinez-Maza R, Nunez E, Roux M, Supplisson S, Aragon C (1998) Differential properties of two stably expressed brain-specific glycine transporters. J Neurochem 71:2211–2219
Lopez-Corcuera B, Nunez E, Martinez-Maza R, Geerlings A, Aragon C (2001) Substrate-induced conformational changes of extracellular loop 1 in the glycine transporter GLYT2. J Biol Chem 276:43463–43470
Luque JM, Nelson N, Richards JG (1995) Cellular expression of glycine transporter 2 messenger RNA exclusively in rat hindbrain and spinal cord. Neuroscience 64:525–535
Lynch JW (2004) Molecular structure and function of the glycine receptor chloride channel. Physiol Rev 84:1051–1095
Mahendrasingam S, Wallam CA, Hackney CM (2003) Two approaches to double post-embedding immunogold labeling of freeze-substituted tissue embedded in low temperature Lowicryl HM20 resin. Brain Res Brain Res Protoc 11:134–141
Mallorga PJ, Williams JB, Jacobson M, Marques R, Chaudhary A, Conn PJ, Pettibone DJ, Sur C (2003) Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4′-fluorophenyl)-3-(4′phenylphenoxy)propyl])sarcosine. Neuropharmacology 45:585–593
Martina M, Gorfinkel Y, Halman S, Lowe JA, Periyalwar P, Schmidt CJ, Bergeron R (2004) Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. J Physiol 557:489–500
Martina M, ME BT, Halman S, Tsai G, Tiberi M, Coyle JT, Bergeron R (2005) Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice. J Physiol 563:777–793
Martinez-Maza R, Poyatos I, Lopez-Corcuera B, E Nu, Gimenez C, Zafra F, Aragon C (2001) The role of N-glycosylation in transport to the plasma membrane and sorting of the neuronal glycine transporter GLYT2. J Biol Chem 276:2168–2173
Morrow JA, Collie IT, Dunbar DR, Walker GB, Shahid M, Hill DR (1998) Molecular cloning and functional expression of the human glycine transporter GlyT2 and chromosomal localisation of the gene in the human genome. FEBS Lett 439:334–340
Nelson N (1998) The family of Na+/Cl− neurotransmitter transporters. JNeurochem 71:1785–1803
Nishimura T, Fukata Y, Kato K, Yamaguchi T, Matsuura Y, Kamiguchi H, Kaibuchi K (2003) CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth. Nat Cell Biol 5:819–826
Nong Y, Huang YQ, Ju W, Kalia LV, Ahmadian G, Wang YT, Salter MW (2003) Glycine binding primes NMDA receptor internalization. Nature 422:302–307
Nunez E, Aragon C (1994) Structural analysis and functional role of the carbohydrate component of glycine transporter. J Biol Chem 269:16920–16924
Nunez E, Lopez-Corcuera B, Martinez-Maza R, Aragon C (2000a) Differential effects of ethanol on glycine uptake mediated by the recombinant GLYT1 and GLYT2 glycine transporters. Br J Pharmacol 129:802–810
Nunez E, Lopez-Corcuera B, Vazquez J, Gimenez C, Aragon C (2000b) Differential effects of the tricyclic antidepressant amoxapine on glycine uptake mediated by the recombinant GLYT1 and GLYT2 glycine transporters. Br J Pharmacol 129:200–206
Ohno K, Koroll M, El Far O, Scholze P, Gomeza J, Betz H (2004) The neuronal glycine transporter 2 interacts with the PDZ domain protein syntenin-1. Mol Cell Neurosci 26:518–529
Olivares L, Aragon C, Gimenez C, Zafra F (1994) Carboxyl terminusof the glycine transporter GLYT1 is necessary for correct processing of the protein. J Biol Chem 269:28400–28404
Olivares L, Aragon C, Gimenez C, Zafra F (1995) The role of N-glycosylation in the targeting and activity of the GLYT1 glycine transporter. J Biol Chem 270:9437–9442
Olivares L, Aragon C, Gimenez C, Zafra F (1997) Analysis of the transmembrane topology of the glycine transporter GLYT1. J Biol Chem 272:1211–1217
Ponce J, Biton B, Benavides J, Avenet P, Aragon C (2000) Transmembrane domain III plays an important role in ion binding and permeation in the glycine transporter GLYT2. J Biol Chem 275:13856–13862
Pow DV, Hendrickson AE (1999) Distributionof the glycine transporter glyt-1 in mammalian and nonmammalian retinae. Vis Neurosci 16:231–239
Poyatos I, Ponce J, Aragon C, Gimenez C, Zafra F (1997) The glycine transporter GLYT2 is a reliable marker for glycine-immunoreactive neurons. Brain Res Mol Brain Res 49:63–70
Poyatos I, Ruberti F, Martinez-Maza R, Gimenez C, Dotti CG, Zafra F (2000) Polarized distribution of glycine transporter isoforms in epithelial and neuronal cells. Mol Cell Neurosci 15:99–111
Rivera C, Voipio J, Payne JA, Ruusuvuori E, Lahtinen H, Lamsa K, Pirvola U, Saarma M, Kaila K (1999) The K+/Cl− co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 397:251–255
Roux MJ, Supplisson S (2000) Neuronal and glial glycine transporters have different stoichiometries. Neuron 25:373–383
Rudnick G (1998) Bioenergetics of neurotransmitter transport. J Bioenerg Biomembr 30:173–185
Sakata K, Sato K, Schloss P, Betz H, Shimada S, Tohyama M (1997) Characterization of glycine release mediated by glycine transporter 1 stably expressed in HEK-293 cells. Brain Res Mol Brain Res 49:89–94
Sakata Y, Owada Y, Sato K, Kojima K, Hisanaga K, Shinka T, Suzuki Y, Aoki Y, Satoh J, Kondo H, Matsubara Y, Kure S (2001) Structure and expression of the glycine cleavage system in rat central nervous system. Brain Res Mol Brain Res 94:119–130
Singer JH, Talley EM, Bayliss DA, Berger AJ (1998) Development of glycinergic synaptic transmission to rat brain stem motoneurons. J Neurophysiol 80:2608–2620
Smith KE, Borden LA, Hartig PR, Branchek T, Weinshank RL (1992) Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors. Neuron 8:927–935
Steeves CL, Baltz JM (2005) Regulation of intracellular glycine as an organic osmolyte in early preimplantation mouse embryos. J Cell Physiol 204:273–279
Supplisson S, Roux MJ (2002) Why glycine transporters have different stoichiometries. FEBS Lett 529:93–101
Sur C, Kinney GG (2004) The therapeutic potential of glycine transporter-1 inhibitors. Expert Opin Investig Drugs 13:515–521
Tada K, Kure S, Takayanagi M, Kume A, Narisawa K (1992) Non-ketotic hyperglycinemia: a life-threatening disorder in the neonate. Early Hum Dev 29:75–81
Tsai G, Ralph-Williams RJ, Martina M, Bergeron R, Berger-Sweeney J, Dunham KS, Jiang Z, Caine SB, Coyle JT (2004) Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc Natl Acad Sci U S A 101:8485–8490
Verdoorn TA, Kleckner NW, Dingledine R (1987) Rat brain N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Science 238:1114–1116
Vergouwe MN, Tijssen MA, Shiang R, van Dijk JG, al Shahwan S, Ophoff RA, Frants RR (1997) Hyperekplexia-like syndromes without mutations in the GLRA1 gene. Clin Neurol Neurosurg 99:172–178
Wang TF, Ding CN, Wang GS, Luo SC, Lin YL, Ruan Y, Hevner R, Rubenstein JL, Hsueh YP (2004) Identification of Tbr-1/CASK complex target genes in neurons. J Neurochem 91:1483–1492
West KL, Castellini MA, Duncan MK, Bustin M (2004) Chromosomal proteins HMGN3a and HMGN3b regulate the expression of glycine transporter 1. Mol Cell Biol 24:3747–3756
Whitehead KJ, Pearce SM, Walker G, Sundaram H, Hill D, Bowery NG (2004) Positive Nmethyl-D-aspartate receptor modulation by selective glycine transporter-1 inhibition in the rat dorsal spinal cord in vivo. Neuroscience 126:381–390
Zafra F, Aragon C, Olivares L, Danbolt NC, Gimenez C, Storm-Mathisen J (1995) Glycine transporters are differentially expressed among CNS cells. J Neurosci 15:3952–3969
Zafra F, Poyatos I, Gimenez C (1997) Neuronal dependency of the glycine transporter GLYT1 expression in glial cells. Glia 20:155–162
Zeilhofer HU, Studler B, Arabadzisz D, Schweizer C, Ahmadi S, Layh B, Bosl MR, Fritschy JM (2005) Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice. J Comp Neurol 482:123–141
Zhou L, Chillag KL, Nigro MA (2002) Hyperekplexia: a treatable neurogenetic disease. Brain Dev 24:669–674
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gomeza, J., Armsen, W., Betz, H., Eulenburg, V. (2006). Lessons from the Knocked-Out Glycine Transporters. In: Sitte, H.H., Freissmuth, M. (eds) Neurotransmitter Transporters. Handbook of Experimental Pharmacology, vol 175. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29784-7_19
Download citation
DOI: https://doi.org/10.1007/3-540-29784-7_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-29783-3
Online ISBN: 978-3-540-29784-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)